Breast Cancer is a cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare. Each year, an estimated 192,370 women are diagnosed with breast cancer.
For more information, visit the National Cancer Institute.
Treatment at the UAB Comprehensive Cancer Center
The UAB Comprehensive Cancer is recognized nationwide as a leader in the fields of breast cancer treatment and research. Breast cancer patients at the UAB Comprehensive Cancer Center are seen in the center’s state-of-the-art Breast Health Clinic, located on the third floor of The Kirklin Clinic of UAB Hospital. Using an integrated multidisciplinary approach, patients have access to a team of dedicated specialists, including medical oncologists, radiation oncologists, surgical oncologists and radiologists, who work together to design the most effective treatment plan possible. Our physicians are nationally recognized experts and employ today’s leading-edge treatments. The Breast Health Clinic is also home to the Angel Squad, a volunteer group dedicated to providing comfort, hope and compassionate services to breast cancer patients and their caregivers.
Breast Health Clinic:
The Kirklin Clinic of UAB Hospital 3rd Floor
2000 6th Avenue South
Birmingham, AL 35233
(205) 801-8266 or 1-800-333-6543
Breast Cancer Research at the UAB Comprehensive Cancer Center
The UAB Comprehensive Cancer Center is a nationally recognized leader in the field of breast cancer research. The center is one of only 11 institutions in the nation to hold a SPORE (Specialized Program of Research Excellence) grant in breast cancer. These highly prestigious grants are designed to move research findings quickly and safely from the laboratory to the clinical setting.
The Cancer Center is also a member of the Translational Breast Cancer Research Consortium, a national group of 14 research centers that conducts innovative, high-impact clinical trials in breast cancer. Also, in 2009, the Cancer Center was awarded a $6.4-million Promise grant from the Susan G. Komen Foundation to study triple-negative breast cancer, a particularly aggressive form of the disease.